SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5g5n'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AV2_C_DVAC6_0
(GRAMICIDIN A)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A  53
VAL A  75
TRP A  57
None
0.79A 1av2C-5g5nA:
undetectable
1av2D-5g5nA:
undetectable
1av2C-5g5nA:
5.15
1av2D-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GRM_A_DVAA6_0
(GRAMICIDIN A)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A 180
VAL A 204
TRP A 209
None
0.86A 1grmA-5g5nA:
undetectable
1grmA-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GRM_B_DVAB6_0
(GRAMICIDIN A)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A 180
VAL A 204
TRP A 209
None
0.86A 1grmB-5g5nA:
undetectable
1grmB-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KGL_A_RTLA175_1
(CELLULAR
RETINOL-BINDING
PROTEIN TYPE I)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 7 LEU A 266
THR A 120
MET A 123
TRP A 126
None
GOL  A1374 (-3.1A)
GOL  A1374 ( 4.9A)
MMC  A1379 ( 3.4A)
1.24A 1kglA-5g5nA:
undetectable
1kglA-5g5nA:
16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAG_A_DVAA6_0
(GRAMICIDIN A)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A 180
VAL A 204
TRP A 209
None
0.94A 1magA-5g5nA:
undetectable
1magA-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAG_B_DVAB6_0
(GRAMICIDIN A)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A 180
VAL A 204
TRP A 209
None
0.94A 1magB-5g5nA:
undetectable
1magB-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W5U_C_DVAC6_0
(GRAMICIDIN D)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A  53
VAL A  75
TRP A  57
None
0.77A 1w5uC-5g5nA:
undetectable
1w5uD-5g5nA:
undetectable
1w5uC-5g5nA:
5.15
1w5uD-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AOU_B_CQAB401_0
(HISTAMINE
N-METHYLTRANSFERASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 7 GLY A  70
PRO A  51
TYR A  55
THR A  30
None
1.18A 2aouB-5g5nA:
undetectable
2aouB-5g5nA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_A_SAMA2001_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 7 TYR A 255
GLY A 321
THR A 323
TYR A 295
None
0.93A 2g70A-5g5nA:
undetectable
2g70A-5g5nA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_B_SAMB2002_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 7 TYR A 255
GLY A 321
THR A 323
TYR A 295
None
0.89A 2g70B-5g5nA:
undetectable
2g70B-5g5nA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_B_DVAB6_0
(GRAMICIDIN D)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 TRP A  57
ALA A  53
VAL A  75
None
0.82A 2izqA-5g5nA:
undetectable
2izqB-5g5nA:
undetectable
2izqA-5g5nA:
5.15
2izqB-5g5nA:
5.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 9 LEU A  49
ILE A  86
ILE A  83
PRO A  37
ILE A  68
None
1.18A 3d1yB-5g5nA:
undetectable
3d1yB-5g5nA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E00_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 ILE A 179
ALA A 145
VAL A 165
ILE A 132
CYH A 127
None
0.99A 3e00A-5g5nA:
undetectable
3e00A-5g5nA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FAL_A_REAA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 10 ILE A 179
ALA A 145
VAL A 165
ILE A 132
CYH A 127
None
0.89A 3falA-5g5nA:
undetectable
3falA-5g5nA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FZG_A_SAMA300_0
(16S RRNA METHYLASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 GLY A 324
GLY A 318
LEU A 316
VAL A 350
GLN A 370
None
1.28A 3fzgA-5g5nA:
undetectable
3fzgA-5g5nA:
18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW3_A_TOPA208_1
(DIHYDROFOLATE
REDUCTASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 10 ALA A  40
VAL A  60
ILE A  98
LEU A 125
ILE A  62
None
1.00A 3jw3A-5g5nA:
undetectable
3jw3A-5g5nA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW3_B_TOPB208_1
(DIHYDROFOLATE
REDUCTASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 9 ALA A  40
VAL A  60
ILE A  98
LEU A 125
ILE A  62
None
0.99A 3jw3B-5g5nA:
undetectable
3jw3B-5g5nA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L8L_A_DVAA6_0
(GRAMICIDIN D)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A  53
VAL A  75
TRP A  57
None
0.81A 3l8lA-5g5nA:
undetectable
3l8lB-5g5nA:
undetectable
3l8lA-5g5nA:
5.15
3l8lB-5g5nA:
5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L8L_C_DVAC6_0
(GRAMICIDIN D)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ALA A  53
VAL A  75
TRP A  57
None
0.73A 3l8lC-5g5nA:
undetectable
3l8lD-5g5nA:
undetectable
3l8lC-5g5nA:
5.15
3l8lD-5g5nA:
5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P4W_C_DSFC320_1
(GLR4197 PROTEIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 8 TYR A 148
ILE A 147
VAL A 185
ILE A 132
GOL  A1374 ( 4.6A)
None
None
None
0.82A 3p4wC-5g5nA:
undetectable
3p4wC-5g5nA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WS1_A_URFA301_1
(URACIL-DNA
GLYCOSYLASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 8 GLY A 144
GLN A 122
PHE A 115
SER A 116
None
0.90A 4ws1A-5g5nA:
undetectable
4ws1A-5g5nA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0Y_A_FOLA201_0
(CONSERVED
HYPOTHETICAL
MEMBRANE PROTEIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 LEU A 224
SER A 191
ASN A 214
PHE A 245
THR A 210
None
1.43A 5d0yA-5g5nA:
undetectable
5d0yA-5g5nA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0Y_A_FOLA201_0
(CONSERVED
HYPOTHETICAL
MEMBRANE PROTEIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 LEU A 224
SER A 191
ASN A 214
PHE A 245
THR A 246
None
1.36A 5d0yA-5g5nA:
undetectable
5d0yA-5g5nA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0Y_B_FOLB201_0
(CONSERVED
HYPOTHETICAL
MEMBRANE PROTEIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 LEU A 224
SER A 191
ASN A 214
PHE A 245
THR A 210
None
1.43A 5d0yB-5g5nA:
undetectable
5d0yB-5g5nA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0Y_B_FOLB201_0
(CONSERVED
HYPOTHETICAL
MEMBRANE PROTEIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 12 LEU A 224
SER A 191
ASN A 214
PHE A 245
THR A 246
None
1.37A 5d0yB-5g5nA:
undetectable
5d0yB-5g5nA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 9 LEU A  49
ILE A  86
ILE A  83
PRO A  37
ILE A  68
None
1.12A 5kqxB-5g5nA:
undetectable
5kqxB-5g5nA:
14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NUN_A_Z80A201_1
(BETA-LACTOGLOBULIN)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 9 ALA A 180
ILE A 134
ILE A 132
ILE A  86
ALA A 145
None
0.94A 5nunA-5g5nA:
undetectable
5nunA-5g5nA:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OG9_A_TESA503_1
(-)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
5 / 9 LEU A 101
LEU A  49
ILE A  62
LEU A 125
ALA A  40
None
1.33A 5og9A-5g5nA:
undetectable
5og9A-5g5nA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_C_CVIC301_1
(REGULATORY PROTEIN
TETR)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 7 GLN A 227
GLY A 228
ILE A 271
GLN A 199
None
1.11A 5vlmC-5g5nA:
undetectable
5vlmC-5g5nA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_D_CVID301_1
(REGULATORY PROTEIN
TETR)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 8 GLN A 227
GLY A 228
ILE A 271
GLN A 199
None
0.97A 5vlmD-5g5nA:
undetectable
5vlmD-5g5nA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XU8_A_DX4A701_0
(UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 2)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
4 / 8 ASN A 291
SER A 292
GLN A 293
ALA A 315
None
0.97A 5xu8A-5g5nA:
undetectable
5xu8A-5g5nA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6JNH_A_ASCA202_0
(PHOSPHOPANTETHEINE
ADENYLYLTRANSFERASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ASN A  59
PRO A  82
GLN A 122
None
0.79A 6jnhA-5g5nA:
undetectable
6jnhA-5g5nA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6JOG_A_ASCA202_0
(PHOSPHOPANTETHEINE
ADENYLYLTRANSFERASE)
5g5n LH3
HEXON-INTERLACING
CAPSID PROTEIN

(Snake
atadenovirus
A)
3 / 3 ASN A  59
PRO A  82
GLN A 122
None
0.76A 6jogA-5g5nA:
undetectable
6jogA-5g5nA:
18.93